AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 50 filers reported holding AXOVANT GENE THERAPIES LTD in Q3 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $0 | -100.0% | 15 | -98.3% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 865 | +85.6% | 0.00% | – |
| Q1 2020 | $1,000 | -96.4% | 466 | -91.4% | 0.00% | -100.0% |
| Q4 2019 | $28,000 | +40.0% | 5,403 | +66.9% | 0.00% | +100.0% |
| Q3 2019 | $20,000 | -25.9% | 3,237 | -23.3% | 0.00% | -50.0% |
| Q2 2019 | $27,000 | – | 4,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|